The role of the capsaicin 8% patch in the treatment of painful diabetic peripheral neuropathy

Pain Manag. 2022 Jul;12(5):595-609. doi: 10.2217/pmt-2021-0025. Epub 2022 Feb 14.

Abstract

Treatment of painful diabetic peripheral neuropathy (PDPN) is challenging and often limited by drug tolerability and adverse effects. This review article focuses on the high-dose (8%) capsaicin patch that allows for improved efficacy and reduced application frequency in comparison to low-dose capsaicin formulations. Systemic absorption is minimal resulting in fewer systemic side effects than first-line oral medications. There is evidence that capsaicin patch treatment is well-tolerated, safe and provides effective pain relief maintained for several weeks; well-powered studies are needed to confirm these findings. The capsaicin 8% patch may benefit patients at high risk for adverse effects from oral medication, polypharmacy or inadequate pain relief from first-line therapies.

Keywords: neurology; neuropathic pain; pain; pain management; peripheral neuropathies.

Plain language summary

Treatment of nerve pain in the feet and other regions due to nerve damage from diabetes is challenging, often due to the unwanted side effects of medications. This review article focuses on the high-dose (8%) capsaicin patch, which can be applied directly to the feet. It is more potent than the low-dose formulations, allowing patients to apply it less often while also working more effectively compared with low-dose capsaicin creams. Because it acts directly on the skin, there are fewer systemic side effects such as drowsiness or urinary retention. There is evidence that capsaicin patch treatment is safe and provides pain relief for several weeks. More large studies are needed to confirm these findings. The capsaicin 8% patch may benefit patients at high risk for side effects from oral medications or inadequate pain relief from first-line medications.

Publication types

  • Review

MeSH terms

  • Capsaicin / adverse effects
  • Diabetes Mellitus* / chemically induced
  • Diabetes Mellitus* / drug therapy
  • Diabetic Neuropathies* / chemically induced
  • Diabetic Neuropathies* / drug therapy
  • Humans
  • Neuralgia* / drug therapy
  • Pain Management

Substances

  • Capsaicin